Expanded Access of Pimavanserin for Patients With PD Psychosis
Clinical trial NCT02762591 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02762591
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.